CLINICAL PHARMACOLOGICAL APPROACH TO THE USE OF IMMUNOCORRECTORS IN IMMUNE INFLAMMATORY DISEASES
Keywords:
respiratory infections, resistance, immunity, immunomodulatorsAbstract
The review presents the results of a comprehensive study of the main properties of the therapeutic molecule azoximer bromide (polyoxidonium). The experience of using the immunomodulator in acute respiratory infections is analyzed. Polyoxidonium has a pronounced immunomodulatory (including interferon-producing) activity, has a non-specific protective effect against a wide range of pathogens, based not on direct inhibition of microorganisms, but on the regulation of the immunity of the macroorganism. In addition, the drug has antitoxic and antioxidant properties. In the acute period of the disease, azoximer bromide is used in combination with etiotropic therapy, and during the rehabilitation period or for the purpose of immunoprophylaxis of respiratory infections - as monotherapy.
References
Kryzhanovsky G.N. Some general pathological
and biological categories: health, disease,
homeostasis, sanogenesis, adaptation,
immunity. New approaches and definitions.
Pat Physiol 2014; 3: 3–7.2. Beceiro A., Tomás M., Bou G. Antimicrobial
Resistance and Virulence: a Successful or
Deleterious Association in the Bacterial World?
Clin Microbiol Rev 2013; 26 (2): 185–230.
Noel M.K. Immunomodulators in infectious
diseases: panoply of possibilities. Inter
Immunopharm 2010; 22 (12): 1083–1091.
Karaulov A.V., Kalyuzhin O.V. Immunotherapy
of infectious diseases: problems and
prospects. Ter arkh 2013; 11: 100–108.
Kozlov I.G. Signaling receptors of innate
immunity: a new molecular target for
diagnostics and therapy of inflammatory
diseases. Vestn RAMS 2011; 1: 42–50.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
